Bolt Biotherapeutics Inc

NASDAQ:BOLT   3:59:57 PM EDT
1.55
-0.08 (-4.91%)
Earnings Announcements

Bolt Biotherapeutics Reports Q4 Financial Results

Published: 03/30/2022 20:21 GMT
Bolt Biotherapeutics Inc (BOLT) - Bolt Biotherapeutics Reports Four Quarter and Full Year 2021 Financial Results and Provides Business Highlights.
Quarterly Revenue $500,000.
Bolt Biotherapeutics - Cash, Cash Equivalents, Marketable Securities Were $271.6 Million As of Dec 31, 2021, Compared to $22.8 Million As of Dec 31, 2020.
Expects Its Cash Balance to Fund Operations Into 2024.
Revenue is expected to be $0.5 Million
Adjusted EPS is expected to be -$0.66

Next Quarter Revenue Guidance is expected to be $0.5 Million
Next Quarter EPS Guidance is expected to be -$0.68

More details on our Analysts Page.